F

Filana Therapeutics Inc
D

FLNA

1.19500
USD
0.03
(2.58%)
مغلق
حجم التداول
8,203
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
57,727,936
المقالات
المزيد

العنوان: Filana Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-relatedepilepsy.